Koninklijke Philips (NYSE:PHG – Get Free Report) was the recipient of a significant drop in short interest in December. As of December 15th, there was short interest totalling 1,680,000 shares, a drop of 25.3% from the November 30th total of 2,250,000 shares. Based on an average daily trading volume, of 756,600 shares, the days-to-cover ratio is presently 2.2 days.
Institutional Investors Weigh In On Koninklijke Philips
Several hedge funds have recently bought and sold shares of PHG. Wilmington Savings Fund Society FSB bought a new stake in Koninklijke Philips in the 3rd quarter valued at approximately $54,000. Fairscale Capital LLC bought a new position in Koninklijke Philips in the 2nd quarter valued at about $54,000. Eastern Bank bought a new stake in Koninklijke Philips in the 3rd quarter valued at $88,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Koninklijke Philips in the third quarter valued at about $107,000. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Koninklijke Philips by 182.4% during the second quarter. Allspring Global Investments Holdings LLC now owns 5,657 shares of the technology company’s stock worth $143,000 after purchasing an additional 3,654 shares during the period. 13.67% of the stock is currently owned by institutional investors and hedge funds.
Koninklijke Philips Stock Performance
Shares of NYSE PHG traded down $0.20 during mid-day trading on Friday, hitting $25.57. The company had a trading volume of 384,605 shares, compared to its average volume of 930,287. Koninklijke Philips has a 12 month low of $19.55 and a 12 month high of $32.91. The firm has a market cap of $24.03 billion, a P/E ratio of -60.88, a PEG ratio of 0.92 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The business’s 50-day simple moving average is $26.78 and its 200-day simple moving average is $28.10.
Analysts Set New Price Targets
View Our Latest Stock Analysis on PHG
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- Why is the Ex-Dividend Date Significant to Investors?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Stock Market Upgrades: What Are They?
- Top 3 ETFs to Hedge Against Inflation in 2025
- How to Invest in Insurance Companies: A GuideĀ
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.